Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency
Wu Zhong, Yongdong Niu, Haorui Lin, Danmei Huang et al.
Citations
3 citations
Journal
Current Pharmaceutical Design
Topics
Computational Drug Discovery Methods
Field-Weighted Citation Impact (FWCI)
4.51
article
Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency
Wu Zhong, Yongdong Niu, Haorui Lin, Danmei Huang, Zhanqin Huang, Yaqi Xing, Zhiming Chen, Tao Chen, Ling Chen, Jun Lü, Shuli Xie, Mohamed S. Nawaz
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Current Pharmaceutical DesignVol. 31(22)
Institutions
Sun Yat-sen University (CN), Shantou University (CN), Cancer Hospital of Shantou University Medical College (CN), First Affiliated Hospital of Shantou University Medical College (CN), Shantou University Medical College (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Crippled Hepatocarcinogenesis Inhibition of Quercetin in Glycolysis Pathway with Hepatic Farnesoid X Receptor Deficiency — Wu Zhong, Yongdong Niu, et al. · Current Pharmaceutical Design (2025) | TGRS Research Map | TGRS